$0.834
-0.010 (-1.18%)收盘时
- High
- 0.863
- Open
- 0.860
- VWAP
- 0.84
- Vol
- 931.68K
- Mkt Cap
- —
- Low
- 0.812
- Amount
- 779.04K
- EV/EBITDA, TTM
- 0.00
Qtrex Quantum Ltd, formerly known as Inspira Technologies Oxy B.H.N Ltd, is an Israel-based company engaged in medical and technological sectors. The Company is a specialty medical device company that is engaged in the research, development, manufacture, and marketing of respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV). The Company focuses on advancing non-invasive or minimally invasive respiratory support technologies intended to reduce reliance on mechanical ventilation and improve patient outcomes in acute care settings. The Firm provides patients with acute respiratory distress syndrome to maintain spontaneous breathing and avoid the various risks associated with the use of MV.
AI analysis of Qtrex Quantum Ltd (QTEX)
holdQTEX is not a strong buy at the moment due to its current price of 0.83, which is significantly below its 200-day simple moving average of 1.358. Additionally, the RSI is at 38.578, indicating the stock is nearing oversold territory but has not yet reversed. The stock has seen a 5-day change of -8.90%, suggesting recent downward momentum, which raises concerns for short-term investors. The main risk is the negative net margin projected for 2025/Q4 at -4574.39%, indicating ongoing financial struggles.
估值指标
事件时间线
资讯
8.508-20NewsfilterQTREX Quantum Secures $10 Million in Direct Offering
3.508-19NewsfilterQTREX Quantum Ltd. Advances Quantum Computing with New Technology
3.507-31NewsfilterQTREX Quantum Platform Exceeds Performance Requirements Set by Strategic Partners
7.507-27GlobenewswireQTREX Launches Quantum Interconnect Research Program with Northeastern University
7.507-27NewsfilterQTREX Launches Quantum Interconnect Research Program with Northeastern University
QTEX FAQ — answered by Alphio AI
Qtrex Quantum Ltd, formerly known as Inspira Technologies Oxy B.H.N Ltd, is an Israel-based company engaged in medical and technological sectors. The Company is a specialty medical device company that is engaged in the research, development, manufacture, and marketing of respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV). The Company focuses on advancing non-invasive or minimally invasive respiratory support technologies intended to reduce reliance on mechanical ventilation and improve patient outcomes in acute care settings. The Firm provides patients with acute respiratory distress syndrome to maintain spontaneous breathing and avoid the various risks associated with the use of MV. It operates in the Healthcare sector.
QTEX is not a strong buy at the moment due to its current price of 0.83, which is significantly below its 200-day simple moving average of 1.358. Additionally, the RSI is at 38.578, indicating the stock is nearing oversold territory but has not yet reversed. The stock has seen a 5-day change of -8.90%, suggesting recent downward momentum, which raises concerns for short-term investors. The main risk is the negative net margin projected for 2025/Q4 at -4574.39%, indicating ongoing financial struggles.
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。